doi: 10.1111/j.1365-2133.1977.tb14133.x.
Topical mechlorethamine therapy for mycosis fungoides
- PMID: 588466
- DOI: 10.1111/j.1365-2133.1977.tb14133.x
Item in Clipboard
Topical mechlorethamine therapy for mycosis fungoides
Br J Dermatol.
1977 Nov.
Abstract
Patients with limited skin involvement by mycosis fungoides were treated with daily topical mechlorethamine. Seven of thirteen patients had a complete remission of diseases. Six of these seven experienced a contact dermatitis and four underwent a successful topical desensitization programme. The possible beneficial therapeutic effects of developing a contact allergy are discussed.
Similar articles
-
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.Drug Des Devel Ther. 2018 Jan 31;12:241-254. doi: 10.2147/DDDT.S137106. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29440874 Free PMC article. Review.
-
Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.Arch Dermatol. 1975 Apr;111(4):484-8. Arch Dermatol. 1975. PMID: 1122150
-
Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.Arch Dermatol. 1977 Oct;113(10):1387-9. doi: 10.1001/archderm.113.10.1387. Arch Dermatol. 1977. PMID: 911166
-
The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapy.Cancer. 1977 Dec;40(6):2851-3. doi: 10.1002/1097-0142(197712)40:6<2851::aid-cncr2820400615>3.0.co;2-x. Cancer. 1977. PMID: 412580 Clinical Trial.
-
Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.Int J Dermatol. 1984 Apr;23(3):180-6. doi: 10.1111/j.1365-4362.1984.tb04507.x. Int J Dermatol. 1984. PMID: 6373639 Review. No abstract available.
Cited by
-
Skin-directed therapy and biologic response modifiers in mycosis fungoides.Dermatol Reports. 2024 May 7;16(Suppl 2):9926. doi: 10.4081/dr.2024.9926. eCollection 2024 May 7. Dermatol Reports. 2024. PMID: 39295879 Free PMC article. Review.
-
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.Drug Des Devel Ther. 2018 Jan 31;12:241-254. doi: 10.2147/DDDT.S137106. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29440874 Free PMC article. Review.
-
Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides.Dermatol Ther (Heidelb). 2022 Mar;12(3):643-654. doi: 10.1007/s13555-022-00681-6. Epub 2022 Feb 5. Dermatol Ther (Heidelb). 2022. PMID: 35122614 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
